Fibroblasts restrain gut inflammation by IGF1-dependent regulation of innate lymphocytes · Q. Lin et al.
原文开头
Qingxia Lin1†, Ruichao E. Liu2,3,4†*, Qiang Wang1†, Lan Kang5†, Boyuan Chen1, Yu Lu2,3, Yanting Zhang1, Zhijie Gu2,3,4, Yu Zhou1, Hongzhi Liu1, Xitao Xu6, Zhijun Cao6, Zirun Tang2,3, Wenxuan Xu2,3, Yi Wang2,3,4, Zhe Cui7, Minhao Yu7, Shanhao Jin8, Quan Zhang8, Chong Liu9,10, Hua Tang11, Xiaoyu Hu12, Gregory F. Sonnenberg5,13,14*, Coco Chu2,3,4,15,16,17*, Lei Zhou1* Fibroblasts exhibit phenotypic and functional heterogeneity in chronic inflammatory diseases, but how these changes impact immune outcomes remains poorly understood. We identified that a fibroblast population expressing insulin-like growth factor 1 (IGF1) was reduced in patients with inflammatory bowel disease (IBD). Using mouse models of intestinal inflammation, we found cross-talk between IGF1-expressing fibroblasts and group 3 innate lymphoid cells (ILC3s). …
摘自《科学》(Science)2026年9月24日,Q. Lin et al.。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。